An anti-SARS-CoV-2 metabolite is reduced in diabetes

View/Open
Author
Vergara-Alert, Júlia ORCID
Izquierdo-Useros, Nuria
Publication date
2022-05-09
URI http://hdl.handle.net/20.500.12327/1902
DOI
https://doi.org/10.1038/s42255-022-00569-x
ISSN
2522-5812
Abstract
A glucose-like metabolite, which is reduced in the serum of diabetic patients, inhibits the entry of SARS-CoV-2 into key cellular targets. The work led by Cheng and colleagues provides a molecular explanation for the increased risk of severe COVID-19 in patients with diabetes.
Document Type
Article
Document version
Accepted version
Language
English
Subject (CDU)
619 - Veterinary science
Pages
4
Publisher
Nature Research
Is part of
Nature Metabolism
Citation
Vergara-Alert, Júlia, and Nuria Izquierdo-Useros. 2022. "An Anti-SARS-Cov-2 Metabolite Is Reduced In Diabetes". Nature Metabolism 4 (5): 501-502. doi:10.1038/s42255-022-00569-x.
Program
Sanitat Animal
Show full item record

This item appears in the following Collection(s)

Rights

Copyright © 2022, Springer Nature Limited

Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint